University of Washington CT expert offers contrast conservation tips
It's definitely possible to reduce CT contrast volume, even in a busy radiology department, according to CT supervisor Gulnoor Sheriff at the University of Washington Medical Center, Montlake, in Seattle.
In fact, by taking practical action, Sheriff and colleagues have achieved an overall contrast volume reduction of more than 20% and saved the department $30,000 annually. How? In part through adopting new technology such as syringeless contrast injectors and making use of dual-energy CT scanners.
"Strategic investments in the right technology is key to CT contrast conservation, coupled with effective education and train...
Source: AuntMinnie.com Headlines - February 26, 2024 Category: Radiology Authors: Kate Madden Yee Tags: Practice Management Source Type: news
Contrast Shortage: D éjà vu All Over Again Contrast Shortage: D éjà vu All Over Again
Reminiscent of the early days of COVID-19 pandemic, a shortage of iohexol is affecting imaging practices as well as anesthesiology.Medscape Medical News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - June 10, 2022 Category: Pathology Tags: Radiology News Source Type: news
Contrast Shortage D éjà vu All Over Again Contrast Shortage D éjà vu All Over Again
Reminiscent of the early days of COVID-19 pandemic, a shortage of iohexol is affecting imaging practices as well as anesthesiology.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 10, 2022 Category: Consumer Health News Tags: Radiology News Source Type: news
Strategies for Addressing Shortage of Iohexol Discussed
TUESDAY, May 24, 2022 -- Strategies for addressing the current shortage of iodinated contrast media (ICM) are discussed in a special report published online May 19 in Radiology.
Noting that a Chinese government lockdown in Shanghai on March 31,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 24, 2022 Category: Pharmaceuticals Source Type: news
Hospitals Face Tough Choices as Lockdown in China Disrupts IV Contrast Supply
(MedPage Today) -- Shortages of iohexol and iodixanol intravenous contrast media products have been reported after a GE Healthcare production facility in Shanghai experienced an unexpected, temporary shutdown last month during a COVID-19-related... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - May 11, 2022 Category: Infectious Diseases Source Type: news
Company led drug alert – Iohexol solution for injection (350mg/ml and 300 mgI/ml)
Glenmark Pharmaceuticals is recalling specific batches of Iohexol solution for injection (350mg/ml and 300 mgI/ml) ... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 6, 2020 Category: Drugs & Pharmacology Source Type: news
Oraltag (Iohexol for Oral Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 2, 2019 Category: Drugs & Pharmacology Source Type: news
Omnipaque (Iohexol Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 24, 2017 Category: Drugs & Pharmacology Source Type: news
IV contrast for CT is not associated with increased risk of acute kidney injury
Intravenous contrast media (typically iohexol or iodixanol) used in computed tomography (CT) does not appear to be associated with chronic kidney disease, dialysis, kidney transplant or acute kidney injury, despite long-held fears to the contrary. The results of the largest controlled study of acute kidney injury following contrast media administration in the emergency department were just published. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 26, 2017 Category: Science Source Type: news
IV contrast for CT is not associated with increased risk of acute kidney injury
(American College of Emergency Physicians) Intravenous contrast media (typically iohexol or iodixanol) used in computed tomography (CT) does not appear to be associated with chronic kidney disease, dialysis, kidney transplant or acute kidney injury, despite long-held fears to the contrary. The results of the largest controlled study of acute kidney injury following contrast media administration in the emergency department were published online yesterday in Annals of Emergency Medicine ('Risk of Acute Kidney Injury Following Intravenous Contrast Media Administration'). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 26, 2017 Category: Global & Universal Source Type: news
